# Dr. Shashidhar Kori

> Dr. Shashidhar "Shashi" Kori is co-founder and CEO of Novilla Pharmaceuticals. His career includes academic appointments, a senior development role at GlaxoSmithKline, vice-presidential roles at MAP Pharmaceuticals and Allergan, and chief medical officer positions at Autonomic Technologies and Trigemina.

- **Role:** Co-Founder & CEO at Novilla Pharmaceuticals
- **Organizations:** Novilla Pharmaceuticals, GlaxoSmithKline, MAP Pharmaceuticals, Allergan, Autonomic Technologies, Trigemina, Exalys Therapeutics, Duke University, Case Western Reserve University, University of South Florida, Memorial Sloan Kettering
- **Education:** Medical degree, Kasturba Medical College, Mangalore, Cornell University
- **Known for:** Built the Medical Affairs department at MAP Pharmaceuticals from the ground up., Recipient of the VSNA 2010 Professional Award., Appointed to senior leadership roles at MAP, Autonomic Technologies and Trigemina.

## Career timeline

- **Before GSK; dates unspecified** — Worked in academic institutions including Duke University, Case Western Reserve University, the University of South Florida and Memorial Sloan Kettering.
- **Before August 2007** — Senior Director of Clinical Development at GlaxoSmithKline.
- **2007** — Appointed Vice President of Clinical Development at MAP Pharmaceuticals on August 10.
- **2010** — Received the VSNA Professional Award; honored at the North California chapter’s November 20 Deepavali celebration.
- **2013** — MAP became an Allergan subsidiary; Kori’s subsequent appointment announcement identifies his vice-presidential service at both companies.
- **2014** — Appointed Chief Medical Officer at Autonomic Technologies in January.
- **2015** — Appointed Chief Medical Officer at Trigemina on August 4.
- **2019** — Novilla dates its founding collaboration between Shashidhar Kori and Eric Fossel to this year.
- **2020** — Named a Tonix consultant in a July 27 company announcement.
- **2021** — Listed with an Exalys Therapeutics affiliation on a co-authored publication.
- **2022-2023** — Listed as a Novilla-affiliated peer reviewer in federal program reviewer lists.

## Achievements

- Built the Medical Affairs department at MAP Pharmaceuticals from the ground up.
- Recipient of the VSNA 2010 Professional Award.
- Appointed to senior leadership roles at MAP, Autonomic Technologies and Trigemina.
- Co-founded Novilla with Eric Fossel in 2019.

## Latest updates

- **2024-04** — The American Academy of Neurology’s 2024 meeting disclosures list Novilla employment, board service and ownership interests; also list several consulting relationships.

## Links

- Website: https://www.novilla.com/about-us
- LinkedIn: https://www.linkedin.com/in/shashi-kori-33a0a38

---

Profile page: https://yespress.io/shashidhar-kori
Published by YesPress — https://yespress.io
Last updated: 2026-10-14